These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Research on the fibrinolytic effects developed in vivo from 7-(2-[pyrid(3)yl-methylamino]ethyl) theophylline nicotinate. Preliminary note]. Preliminare N. Clin Ter; 1974 Nov 30; 71(4):321-33. PubMed ID: 4459005 [No Abstract] [Full Text] [Related]
9. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT. MCNICOL GP, DOUGLAS AS. Br Med J; 1965 May 01; 1(5443):1149-53. PubMed ID: 14273517 [No Abstract] [Full Text] [Related]
12. [Fibrinolytic therapy of cerebral embolism with streptokinase. Case report]. Bouschery R. Med Welt; 1967 Oct 28; 43():2588-9. PubMed ID: 5610300 [No Abstract] [Full Text] [Related]
13. [Effect of Complamin on fibrinolysis and platelet aggregation in the aged]. Matijević N, Sisić I, Korolija P, Pendić B. Bilt Hematol Transfuz; 1980 Oct 28; 8(1):37-43. PubMed ID: 7337681 [Abstract] [Full Text] [Related]
19. [Experience with the clinical use of fibrinolysin]. Panchenko VM. Vrach Delo; 1966 Nov 28; 11():8-11. PubMed ID: 4237274 [No Abstract] [Full Text] [Related]